chevron_leftBack
As of 8 June 2026, China Regenerative Medicine International Ltd. has a market cap of $15.73M USD, ranking #38695 globally and #1159 in Hong Kong.
It ranks #3452 in the Healthcare sector, and #1134 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$15.73MUSD
123.22M HKD
Enterprise Value
$13.57MUSD
106.36M HKD
Revenue (TTM)
$9.2MUSD
72.06M HKD
EBITDA (TTM)
-$118.56KUSD
-929.0K HKD
Net Income (TTM)
$3.51MUSD
27.53M HKD
EBITDA Margin
-1.3%
Profit Margin
38%
PE Ratio
4.5
PS Ratio
1.7
PB Ratio
2.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Chuang Wang
open_in_new
Employees
30
Founded
1995
Website
crmi.hk
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | 2.5% | 8% | 2.5% | -30% | 1.3% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
8158
中國再生醫學國際有限公司
ISIN: KYG2129W1380
Shares Out.:
Shares Outstanding:
304.252M1
Shares Float:
249.2M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.4050 HKD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About China Regenerative Medicine International Ltd.
China Regenerative Medicine International Limited, an investment holding company, provides healthcare products and services in Hong Kong and the People’s Republic of China. The company operates through Aesthetic Medical and Beauty Services; and Medical Services segments. It offers medical beauty products and services; and medical products and services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: RGC
|
$14.32B
91K%
|
-
|
|
SHEK: 1177
|
$12.45B
79K%
97.51B HKD
|
37.8
|
|
SHEK: 3696
|
$4.7B
30K%
36.81B HKD
|
-
|
|
SHEK: 3320
|
$4.2B
27K%
32.92B HKD
|
7.3
|
|
SHEK: 512
|
$2.87B
18K%
22.45B HKD
|
18.1
|
|
|
$2.4B
15K%
18.78B HKD
|
7.7
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
5M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
3M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
2M%
|
97.4
|
|
SIX: RO
|
$322.98B
2M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.68B
2M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$275.9B
2M%
218.9B CHF
|
20.5
|
chevron_leftBack